Cited by

• Cardiovascular resistance to thrombosis in 13-lined ground squirrels.

  Bonis A, Anderson L, Talhouarne G, Schueller E, Unke J, Krus C, Stokka J, Koepke A, Lehrer B, Schuh A, Andersen JJ, Cooper S. Bonis A, et al. J Comp Physiol B. 2019 Feb;189(1):167-177. doi: 10.1007/s00360-018-1186-x. Epub 2018 Oct 13. J Comp Physiol B. 2019. PMID: 30317383 Free PMC article.
• Antithrombin III for critically ill patients.

  Allingstrup M, Wetterslev J, Ravn FB, Møller AM, Afshari A. Allingstrup M, et al. Cochrane Database Syst Rev. 2016 Feb 8;2(2):CD005370. doi: 10.1002/14651858.CD005370.pub3. Cochrane Database Syst Rev. 2016. PMID: 26858174 Free PMC article.
• Antithrombin III and sepsis.

  Mammen EF. Mammen EF. Intensive Care Med. 1998 Jul;24(7):649-50. doi: 10.1007/s001340050639. Intensive Care Med. 1998. PMID: 9722032 Review. No abstract available.
• The effect of Antithrombin-III on routine hematological and biochemical parameters in an experimental animal model of skeletal muscle ischemia-reperfusion injury.

  Karamanos D, Karkos C, Kambaroudis A, Kritsepi M, Papadopoulos S, Spyridis C, Gerassimidis Ts. Karamanos D, et al. Hippokratia. 2014 Jul-Sep;18(3):234-9. Hippokratia. 2014. PMID: 25694758 Free PMC article.
• Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study.

  Baudo F, Caimi TM, de Cataldo F, Ravizza A, Arlati S, Casella G, Carugo D, Palareti G, Legnani C, Ridolfi L, Rossi R, D'Angelo A, Crippa L, Giudici D, Gallioli G, Wolfler A, Calori G. Baudo F, et al. Intensive Care Med. 1998 Apr;24(4):336-42. doi: 10.1007/s001340050576. Intensive Care Med. 1998. PMID: 9609411 Clinical Trial.